167 related articles for article (PubMed ID: 17332341)
1. GATA-1 is essential in EGF-mediated induction of nucleotide excision repair activity and ERCC1 expression through ERK2 in human hepatoma cells.
Andrieux LO; Fautrel A; Bessard A; Guillouzo A; Baffet G; Langouët S
Cancer Res; 2007 Mar; 67(5):2114-23. PubMed ID: 17332341
[TBL] [Abstract][Full Text] [Related]
2. MAPK dependence of DNA damage repair: ionizing radiation and the induction of expression of the DNA repair genes XRCC1 and ERCC1 in DU145 human prostate carcinoma cells in a MEK1/2 dependent fashion.
Yacoub A; Park JS; Qiao L; Dent P; Hagan MP
Int J Radiat Biol; 2001 Oct; 77(10):1067-78. PubMed ID: 11682011
[TBL] [Abstract][Full Text] [Related]
3. Nucleotide excision repair is not required for the antiapoptotic function of insulin-like growth factor 1.
Lee-Kwon W; Park D; Bernier M
Exp Cell Res; 1998 Jun; 241(2):458-66. PubMed ID: 9637787
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of the two nucleotide excision repair genes ERCC1 and XPC in human hepatocellular carcinoma.
Fautrel A; Andrieux L; Musso O; Boudjema K; Guillouzo A; Langouët S
J Hepatol; 2005 Aug; 43(2):288-93. PubMed ID: 15922480
[TBL] [Abstract][Full Text] [Related]
5. Activation of extracellular signal-regulated kinase signaling by epidermal growth factor mediates c-Jun activation and p300 recruitment in keratin 16 gene expression.
Wang YN; Chen YJ; Chang WC
Mol Pharmacol; 2006 Jan; 69(1):85-98. PubMed ID: 16214953
[TBL] [Abstract][Full Text] [Related]
6. Resistance to mitogen-activated protein kinase kinase (MEK) inhibitors correlates with up-regulation of the MEK/extracellular signal-regulated kinase pathway in hepatocellular carcinoma cells.
Yip-Schneider MT; Klein PJ; Wentz SC; Zeni A; Menze A; Schmidt CM
J Pharmacol Exp Ther; 2009 Jun; 329(3):1063-70. PubMed ID: 19258520
[TBL] [Abstract][Full Text] [Related]
7. [The role of extracellular signal-regulated kinase/mitogen-activated protein kinase pathway in multidrug resistance of hepatocellular carcinoma].
Zhu H; Chen XP; Luo SF; Guan J; Zhang WG; Zhang BX; Mao CP
Zhonghua Wai Ke Za Zhi; 2007 Jul; 45(13):917-20. PubMed ID: 17953842
[TBL] [Abstract][Full Text] [Related]
8. Adenosine A2A receptor occupancy stimulates collagen expression by hepatic stellate cells via pathways involving protein kinase A, Src, and extracellular signal-regulated kinases 1/2 signaling cascade or p38 mitogen-activated protein kinase signaling pathway.
Che J; Chan ES; Cronstein BN
Mol Pharmacol; 2007 Dec; 72(6):1626-36. PubMed ID: 17872970
[TBL] [Abstract][Full Text] [Related]
9. Overactivation of the MEK/ERK pathway in liver tumor cells confers resistance to TGF-{beta}-induced cell death through impairing up-regulation of the NADPH oxidase NOX4.
Caja L; Sancho P; Bertran E; Iglesias-Serret D; Gil J; Fabregat I
Cancer Res; 2009 Oct; 69(19):7595-602. PubMed ID: 19773433
[TBL] [Abstract][Full Text] [Related]
10. PI3K-Akt signaling regulates basal, but MAP-kinase signaling regulates radiation-induced XRCC1 expression in human tumor cells in vitro.
Toulany M; Dittmann K; Fehrenbacher B; Schaller M; Baumann M; Rodemann HP
DNA Repair (Amst); 2008 Oct; 7(10):1746-56. PubMed ID: 18678286
[TBL] [Abstract][Full Text] [Related]
11. Id1 is down-regulated by hepatocyte growth factor via ERK-dependent and ERK-independent signaling pathways, leading to increased expression of p16INK4a in hepatoma cells.
Ushio K; Hashimoto T; Kitamura N; Tanaka T
Mol Cancer Res; 2009 Jul; 7(7):1179-88. PubMed ID: 19567783
[TBL] [Abstract][Full Text] [Related]
12. EGF stimulates uPAR expression and cell invasiveness through ERK, AP-1, and NF-kappaB signaling in human gastric carcinoma cells.
Baek MK; Kim MH; Jang HJ; Park JS; Chung IJ; Shin BA; Ahn BW; Jung YD
Oncol Rep; 2008 Dec; 20(6):1569-75. PubMed ID: 19020743
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C virus E2 protein promotes human hepatoma cell proliferation through the MAPK/ERK signaling pathway via cellular receptors.
Zhao LJ; Wang L; Ren H; Cao J; Li L; Ke JS; Qi ZT
Exp Cell Res; 2005 Apr; 305(1):23-32. PubMed ID: 15777784
[TBL] [Abstract][Full Text] [Related]
14. Epidermal growth factor-induced cyclooxygenase-2 expression in oral squamous cell carcinoma cell lines is mediated through extracellular signal-regulated kinase 1/2 and p38 but is Src and nuclear factor-kappa B independent.
Husvik C; Bryne M; Halstensen TS
Eur J Oral Sci; 2009 Oct; 117(5):528-35. PubMed ID: 19758248
[TBL] [Abstract][Full Text] [Related]
15. Activation of nonsteroidal anti-inflammatory drug-activated gene-1 via extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase revealed a isochaihulactone-triggered apoptotic pathway in human lung cancer A549 cells.
Chen YL; Lin PC; Chen SP; Lin CC; Tsai NM; Cheng YL; Chang WL; Lin SZ; Harn HJ
J Pharmacol Exp Ther; 2007 Nov; 323(2):746-56. PubMed ID: 17715378
[TBL] [Abstract][Full Text] [Related]
16. MEK/ERK-dependent uPAR expression is required for motility via phosphorylation of P70S6K in human hepatocarcinoma cells.
Bessard A; Frémin C; Ezan F; Coutant A; Baffet G
J Cell Physiol; 2007 Aug; 212(2):526-36. PubMed ID: 17427199
[TBL] [Abstract][Full Text] [Related]
17. Growth-related signaling regulates activation of telomerase in regenerating hepatocytes.
Inui T; Shinomiya N; Fukasawa M; Kobayashi M; Kuranaga N; Ohkura S; Seki S
Exp Cell Res; 2002 Feb; 273(2):147-56. PubMed ID: 11822870
[TBL] [Abstract][Full Text] [Related]
18. Oncogenic H-Ras up-regulates expression of ERCC1 to protect cells from platinum-based anticancer agents.
Youn CK; Kim MH; Cho HJ; Kim HB; Chang IY; Chung MH; You HJ
Cancer Res; 2004 Jul; 64(14):4849-57. PubMed ID: 15256455
[TBL] [Abstract][Full Text] [Related]
19. Excision repair cross complementing-group 1: gene expression and platinum resistance.
Altaha R; Liang X; Yu JJ; Reed E
Int J Mol Med; 2004 Dec; 14(6):959-70. PubMed ID: 15547660
[TBL] [Abstract][Full Text] [Related]
20. A role for Akt in epidermal growth factor-stimulated cell cycle progression in cultured hepatocytes: generation of a hyperproliferative window after adenoviral expression of constitutively active Akt.
Luo Y; Dixon CJ; Hall JF; White PJ; Boarder MR
J Pharmacol Exp Ther; 2007 Jun; 321(3):884-91. PubMed ID: 17371807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
